Neural Network Modeling of Voluntary Single-Joint Movement Organization II. Parkinson’s Disease

The organization of voluntary movement is disrupted in Parkinson's disease. The neural network models of voluntary movement preparation and execution presented in the previous chapter are extended here by studying the effects of dopamine depletion in the output of the basal ganglia and in key neuronal types in the cortex and spinal cord. The resulting extended DA–VITE–FLETE model offers an integrative perspective on corticospinal control of Parkinsonian voluntary movement. The model accounts for most of the known empirical signatures of Parkinsonian willful action.

[1]  A. W. Wiegner,et al.  Role of agonist and antagonist muscles in fast arm movements in man , 2004, Experimental Brain Research.

[2]  D. Geschwind,et al.  Distribution of major neurotransmitter receptors in the motor and somatosensory cortex of the rhesus monkey , 1989, Neuroscience.

[3]  O. Hornykiewicz,et al.  Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) , 1990, Neurochemistry International.

[4]  S. Gentleman,et al.  Spinal cord dopaminergic neurons: Evidence for an uncrossed nigrospinal pathway , 1979, Neuropharmacology.

[5]  G. Stelmach,et al.  Force production characteristics in Parkinson's disease , 1989, Experimental Brain Research.

[6]  C. Ghez,et al.  Trajectory control in targeted force impulses , 1987, Experimental Brain Research.

[7]  R. Tanaka,et al.  Disorder in reciprocal innervation upon initiation of voluntary movement in patients with Parkinson's disease , 2004, Experimental Brain Research.

[8]  C. Marsden,et al.  Performance of simultaneous movements in patients with Parkinson's disease. , 1986, Brain : a journal of neurology.

[9]  J. Cooke,et al.  Movement-related phasic muscle activation. II. Generation and functional role of the triphasic pattern. , 1990, Journal of neurophysiology.

[10]  J C Rothwell,et al.  Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[11]  G. Stelmach,et al.  Movement accuracy constraints in Parkinson’s disease patients , 2000, Neuropsychologia.

[12]  G. Stelmach,et al.  Interlimb coordination in Parkinson's disease , 1992, Movement disorders : official journal of the Movement Disorder Society.

[13]  A. Benazzouz,et al.  MPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies , 2004, Experimental Brain Research.

[14]  Howard N. Zelaznik,et al.  Advances in Motor Learning and Control , 1996 .

[15]  A. Carlsson,et al.  3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists , 1957, Nature.

[16]  A. Björklund,et al.  Evidence for a major spinal cord projection from the diencephalic A11 dopamine cell group in the rat using transmitter-specific fluorescent retrograde tracing , 1979, Brain Research.

[17]  Stavros J. Perantonis,et al.  A neural network model of Parkinson's disease bradykinesia , 2006, Neural Networks.

[18]  K. Flowers Visual "closed-loop" and "open-loop" characteristics of voluntary movement in patients with Parkinsonism and intention tremor. , 1976, Brain : a journal of neurology.

[19]  Vassilis Cutsuridis,et al.  Neural Model of Dopaminergic Control of Arm Movements in Parkinson's Disease Bradykinesia , 2006, ICANN.

[20]  M L Latash,et al.  Organizing principles for single joint movements: V. Agonist-antagonist interactions. , 1992, Journal of neurophysiology.

[21]  C. Ghez,et al.  Trajectory control in targeted force impulses , 1987, Experimental Brain Research.

[22]  T. Ebner,et al.  Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-induced hemiparkinsonism on the kinematics of a two-dimensional, multijoint arm movement in the rhesus monkey , 1992, Neuroscience.

[23]  J. Weil-Fugazza,et al.  Dorsal and ventral dopaminergic innervation of the spinal cord: Functional implications , 1993, Brain Research Bulletin.

[24]  C Ghez,et al.  Trajectory control in targeted force impulses , 2004, Experimental Brain Research.

[25]  J. Chalmers,et al.  Direct projection of catecholamine (presumably dopamine)-containing neurons from hypothalamus to spinal cord , 1979, Neuroscience Letters.

[26]  R. Roth,et al.  MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate , 1990, Neuroscience Letters.

[27]  Gibberd Fb The management of Parkinson's disease. , 1986 .

[28]  J. Morrison,et al.  Brainstem dopaminergic neurons project to monkey parietal cortex , 1988, Neuroscience Letters.

[29]  J. Seal,et al.  Neuronal Activity in Area 4 and Movement Parameters Recorded in Trained Monkeys After Unilateral Lesion of the Substantia Nigra , 1983 .

[30]  B. Berger,et al.  Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease , 1991, Annals of neurology.

[31]  M. Yoshida,et al.  A new dopaminergic terminal plexus in the ventral horn of the rat spinal cord. Immunohistochemical studies at the light and electron microscopic levels , 1990, Experientia.

[32]  L. Tremblay,et al.  Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism , 1989, Brain Research.

[33]  J. Kaas,et al.  Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys , 1992, The Journal of comparative neurology.

[34]  G. Stelmach,et al.  Parkinsonian arm movements as altered by task difficulty. , 1996, Parkinsonism & related disorders.

[35]  J. Cooke,et al.  Movement-related phasic muscle activation. I. Relations with temporal profile of movement. , 1990, Journal of neurophysiology.

[36]  B. Berger,et al.  Regional and laminar distribution of the dopamine and serotonin innervation in the macaque cerebral cortex: A radioautographic study , 1988, The Journal of comparative neurology.

[37]  J Jacquy,et al.  Parkinsonian bradykinesia is due to depression in the rate of rise of muscle activity , 1992, Annals of neurology.

[38]  M. Hallett,et al.  A physiological mechanism of bradykinesia. , 1980, Brain : a journal of neurology.

[39]  M. Hallett,et al.  Ballistic flexion movements of the human thumb. , 1979, The Journal of physiology.

[40]  B. Bioulac,et al.  Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons , 2004, Experimental Brain Research.

[41]  B. Bioulac,et al.  MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study , 1985, Brain Research.

[42]  R. Watts,et al.  The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism. , 1992, Neurologic clinics.

[43]  Vassilis Cutsuridis,et al.  Does Abnormal spinal Reciprocal Inhibition lead to Co-Contraction of Antagonist Motor Units? A Modeling Study , 2007, Int. J. Neural Syst..

[44]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[45]  Sanford P. Markey,et al.  Chronic parkinsonism secondary to intravenous injection of meperidine analogues , 1979, Psychiatry Research.

[46]  J. Cooke,et al.  Initial agonist burst duration depends on movement amplitude , 2004, Experimental Brain Research.

[47]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P S Goldman-Rakic,et al.  Widespread origin of the primate mesofrontal dopamine system. , 1998, Cerebral cortex.

[49]  M. Hallett,et al.  EMG analysis of stereotyped voluntary movements in man. , 1975, Journal of neurology, neurosurgery, and psychiatry.

[50]  J. Abbs,et al.  Task-dependent variations in parkinsonian motor impairments. , 1991, Brain : a journal of neurology.

[51]  Y. Agid,et al.  Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.